Health ❯ Healthcare

Diabetes

Type 2 Diabetes Type 1 Diabetes Diabetes Management Insulin Complications Medications Management Treatment Insulin Treatment Treatment Options Clinical Trials Obesity Diabetes Medications Weight Loss Hypoglycemia GLP-1 Medications Monitoring Devices Monitoring Insulin Therapy Technology GLP-1 Agonists Type 1 and Type 2 Diabetes Anti-Diabetic Drugs GLP-1 Receptor Agonists Prediabetes Blood Sugar Control Space Medicine Diabetes Prevention Diabetic Complications AI in Healthcare Diabetes Treatment Type 2 Diabetes Treatments Pharmaceutical Research Side Effects Type 2 Diabetes Management School Health Insulin Delivery Systems Diabetes Screening Diabetic Foot Care Weight Management Continuous Glucose Monitoring Prevention Research Diabetes Mellitus Blood Sugar Monitoring Chronic Kidney Disease Insulin Delivery Drug Development Patient Care Screening Tests Medical Conditions Screening Autoimmune Diseases Patient Education Insulin Types Chronic Conditions Treatment Innovations Adolescent Health Type 2 diabetes Diabetes Treatments HbA1c Management Hormonal Influence Management Strategies Treatment Strategies Treatment Methods Diabetic Retinopathy Software Issues Insulin Access Glucose Monitoring

Stopping GLP-1 Weight-Loss Drugs Before Pregnancy Linked to Higher Gestational Risks, Study Finds

The retrospective Mass General Brigham analysis of 2016–2025 deliveries appears in JAMA Network Open.

Lancet Phase 3 Trial Shows Oral GLP-1 Orforglipron Aids Weight Loss and Diabetes Control

Polymer Lets Insulin Cross Skin in Animals, Matching Injections in Early Tests

EU Medicines Panel Backs Teizeild to Delay Type 1 Diabetes Onset

JAMA Meta-Analyses at Kidney Week Back Routine SGLT2 Inhibitors Across Kidney Function

Lilly to Launch Late-Stage Trials of Amylin Obesity Drug After 20% Weight Loss in Mid-Stage Study

AI App Matches Human-Led Diabetes Prevention in Phase 3 Trial

Lilly’s Oral GLP-1 Orforglipron Beats Farxiga and Placebo in Two Phase 3 Diabetes Trials

Neil Diamond Receives Carousel Ball Honor, Delivers Rare Sweet Caroline Duet

Biomea Fusion Prices Equity Offering With Warrants to Raise About $25 Million

Costco to Offer Ozempic and Wegovy for $499 a Month to Self-Pay Members Nationwide

Study Finds CGMs Track HbA1c in Type 2 Diabetes but Not in People Without Diabetes

Arecor and Sequel to Co-Develop AT278 With Twiist AID for High-Dose Diabetes Care

Phase 3 Trials Show Greater Weight Loss With 7.2 mg Injection and 25 mg Oral Semaglutide

Cue-Driven Eaters Lose More Weight on GLP-1 Drugs, Japanese Study Finds

Bariatric Surgery Outperforms GLP-1 Medicines Over 10 Years for Patients With Diabetes and Obesity

Half of Semaglutide Users Quit Within a Year as Higher Dose Trials Show Bigger Losses, More Side Effects

Lilly’s Orforglipron Pill Hits Phase 3 Goals, Clearing Path to Global Filings

JAMA Studies Find Rare Optic-Nerve Risks With Semaglutide and Tirzepatide

Tandem Diabetes Announces Urgent Medical Device Correction for t:slim X2 Pumps